D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 92 Citations 28,579 246 World Ranking 155 National Ranking 78
Medicine D-index 74 Citations 28,800 214 World Ranking 12426 National Ranking 6584

Research.com Recognitions

Awards & Achievements

Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Antibiotics

The scientist’s investigation covers issues in Microbiology, Candida albicans, Biofilm, Pharmacokinetics and Pharmacodynamics. David R. Andes has researched Microbiology in several fields, including Fungal genetics and In vivo. His Candida albicans research includes themes of Prospective cohort study, Fungal protein and Gene expression profiling.

His Biofilm research is multidisciplinary, incorporating elements of Extracellular matrix, Cell biology, Cell adhesion and Antifungal. His work deals with themes such as Streptococcus pneumoniae and Drug, which intersect with Pharmacokinetics. His Drug study which covers Regimen that intersects with Intensive care medicine.

His most cited work include:

  • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. (2609 citations)
  • Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (1207 citations)
  • Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database (966 citations)

What are the main themes of his work throughout his whole career to date?

David R. Andes spends much of his time researching Microbiology, Pharmacodynamics, Candida albicans, Pharmacology and Pharmacokinetics. David R. Andes has researched Microbiology in several fields, including Staphylococcus aureus, In vivo and Biofilm. His study looks at the relationship between Pharmacodynamics and topics such as Dosing, which overlap with Intensive care medicine.

The various areas that he examines in his Candida albicans study include Fluconazole, Fungal protein and Cell biology. His work in Pharmacology covers topics such as Echinocandin which are related to areas like Anidulafungin. The concepts of his Pharmacokinetics study are interwoven with issues in Minimum inhibitory concentration, Antimicrobial, Antibiotics and Drug.

He most often published in these fields:

  • Microbiology (37.93%)
  • Pharmacodynamics (26.53%)
  • Candida albicans (25.46%)

What were the highlights of his more recent work (between 2016-2021)?

  • Pharmacodynamics (26.53%)
  • Pharmacology (25.46%)
  • Microbiology (37.93%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Pharmacodynamics, Pharmacology, Microbiology, Candida albicans and Pharmacokinetics. His Pharmacodynamics study combines topics from a wide range of disciplines, such as Antibiotics, Micafungin, Intensive care medicine, Staphylococcus aureus and Dosing. His Pharmacology research includes themes of Echinocandin and In vivo.

In his research on the topic of Microbiology, Polymyxin and Polymyxin B is strongly related with Pseudomonas aeruginosa. His studies deal with areas such as Fluconazole, Cell biology and Biofilm as well as Candida albicans. His Pharmacokinetics study also includes

  • Drug that intertwine with fields like Aspergillosis,
  • Klebsiella pneumoniae which intersects with area such as Enterobacteriaceae.

Between 2016 and 2021, his most popular works were:

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. (73 citations)
  • The antimicrobial potential of Streptomyces from insect microbiomes (68 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Bacteria

His scientific interests lie mostly in Pharmacology, Pharmacodynamics, Candida albicans, Pharmacokinetics and Biofilm. David R. Andes has included themes like Micafungin, Pseudomonas aeruginosa, Cmax, Enterobacteriaceae and Drug in his Pharmacodynamics study. His work in the fields of Candida albicans, such as Corpus albicans and Candida parapsilosis, intersects with other areas such as Ebselen.

His Pharmacokinetics study integrates concerns from other disciplines, such as Potency, Staphylococcus aureus, In vivo and Liter. He combines subjects such as Streptococcus mutans, Antifungal drug, High morbidity and Microbiology with his study of Biofilm. In most of his Microbiology studies, his work intersects topics such as Klebsiella pneumoniae.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Peter G. Pappas;Carol A. Kauffman;David Andes;Daniel K. Benjamin.
Clinical Infectious Diseases (2009)

3964 Citations

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy.
Clinical Infectious Diseases (2016)

2402 Citations

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database

Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander.
Clinical Infectious Diseases (2010)

1519 Citations

Clinical practice guideline: Adult sinusitis

Richard M. Rosenfeld;David Andes;Neil Bhattacharyya;Dickson Cheung.
Otolaryngology-Head and Neck Surgery (2007)

1439 Citations

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy.
Clinical Infectious Diseases (2016)

1327 Citations

Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

Peter G. Pappas;Barbara D. Alexander;David R. Andes;Susan Hadley.
Clinical Infectious Diseases (2010)

1251 Citations

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials

David R. Andes;Nasia Safdar;John W. Baddley;Geoffrey Playford.
Clinical Infectious Diseases (2012)

671 Citations

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.

William A. Craig;David Andes.
Pediatric Infectious Disease Journal (1996)

600 Citations

Inhibition of mutation and combating the evolution of antibiotic resistance.

Ryan T Cirz;Jodie K Chin;David R Andes;Valérie de Crécy-Lagard.
PLOS Biology (2005)

565 Citations

A Recently Evolved Transcriptional Network Controls Biofilm Development in Candida albicans

Clarissa J. Nobile;Emily P. Fox;Jeniel E. Nett;Trevor R. Sorrells.
Cell (2012)

550 Citations

Editorial Boards

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David R. Andes

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 146

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 137

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 135

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 130

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 120

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 114

William W. Hope

William W. Hope

University of Liverpool

Publications: 107

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 107

Johan W. Mouton

Johan W. Mouton

Erasmus University Rotterdam

Publications: 103

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 102

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 99

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 98

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 97

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 93

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 92

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 92

Something went wrong. Please try again later.